Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus

被引：34
|
作者：
McCance, D. R. [1 ]
Damm, P. [2 ]
Mathiesen, E. R. [3 ]
Hod, M. [4 ]
Kaaja, R. [5 ]
Dunne, F.
Jensen, L. E. [6 ]
Mersebach, H. [6 ]
机构：
[1] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland
[2] Univ Copenhagen Hosp, Dept Obstet, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark
[4] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Helen Schneider Hosp Women,Perinatal Div, IL-49100 Petah Tiqwa, Israel
[5] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[6] Novo Nordisk, Global Dev, Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2008年 / 51卷 / 11期
关键词：
human insulin; insulin antibody; insulin aspart; pregnancy; type; 1; diabetes;
D O I：
10.1007/s00125-008-1120-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2141 / 2143
页数：3
相关论文
共 50 条
  • [1] Evaluation of insulin antibodies and placental transfer of insulin aspart in pregnant women with type 1 diabetes mellitus
    D. R. McCance
    P. Damm
    E. R. Mathiesen
    M. Hod
    R. Kaaja
    F. Dunne
    L. E. Jensen
    H. Mersebach
    Diabetologia, 2008, 51 : 2141 - 2143
  • [2] No increase in insulin antibodies and no clear evidence of transfer of insulin aspart across the placenta in pregnant women with type I diabetes
    McCance, David
    Damm, Peter
    Mathiesen, Elisabeth
    Kaaja, Risto
    Dunne, Fidelma
    Hod, Moshe
    Jensen, Linda
    Mersebach, Henriette
    DIABETES, 2007, 56 : A22 - A22
  • [3] PHARMACOKINETICS OF INSULIN ASPART IN PREGNANT WOMEN WITH TYPE 1 DIABETES: EVERY DAY IS DIFFERENT
    Murphy, H. R.
    Goudie, R. J. B.
    Lunn, D.
    Hovorka, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A91 - A91
  • [4] Pharmacokinetics of Insulin Aspart in Pregnant Women With Type 1 Diabetes: Every Day Is Different
    Goudie, Robert J. B.
    Lunn, David
    Hovorka, Roman
    Murphy, Helen R.
    DIABETES CARE, 2014, 37 (06) : E121 - E122
  • [5] Cost-effectiveness of insulin aspart compared to human insulin in pregnant women with type 1 diabetes in the UK
    Lloyd, A.
    Townsend, C.
    Munro, V.
    Twena, N.
    Nielsen, S.
    Holman, A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (03) : 599 - 605
  • [6] Pregnant women with type 1 diabetes mellitus treated by glargine insulin
    Al-Shaikh, AA
    SAUDI MEDICAL JOURNAL, 2006, 27 (04) : 563 - 565
  • [7] Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran
    Nosrati, Marzieh
    Fariman, Soroush Ahmadi
    Saiyarsarai, Parisa
    Nikfar, Shekoufeh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2023, 22 (01) : 817 - 825
  • [8] Insulin aspart in pregnancy: Protocol for a randomized controlled trial comparing the safety and efficacy of insulin aspart and human insulin in the treatment of pregnant women with type 1 diabetes
    Hod, M
    Amiel, S
    Damm, P
    Dunne, F
    Heller, S
    Lertoft, B
    Mathiesen, E
    Mccance, D
    Visser, G
    DIABETES, 2003, 52 : A567 - A567
  • [9] Pharmacoeconomic evaluation of insulin aspart and glargine in type 1 and 2 diabetes mellitus in Iran
    Marzieh Nosrati
    Soroush Ahmadi Fariman
    Parisa Saiyarsarai
    Shekoufeh Nikfar
    Journal of Diabetes & Metabolic Disorders, 2023, 22 : 817 - 825
  • [10] No increase in insulin antibodies during pregnancy in type 1 diabetes treated with insulin aspart
    Mathiesen, E.
    McCance, D.
    Damm, P.
    Kaaja, R.
    Hod, M.
    Dunne, F.
    Jensen, L.
    Mersebach, H.
    DIABETOLOGIA, 2007, 50 : S110 - S110
12345